kamagra rezeptfrei levitra farmaco viagra preise viagra en 24 horas levitra 20mg generique acheter apcalis jelly vente de kamagra en france cialis generika bestellen cialis norge comprar viagra seguro

Tag Archive | "radiation therapy"

Study: Recurrence of SCCOP may differ in HPV-positive and HPV-negative patients

Monday, February 24, 2014

0 Comments

Source: News Medical Published: February 21, 2014   Patients with HPV-positive squamous cell carcinoma of the oropharynx (SCCOP) had a longer time to development of distant metastasis (DM) after initial treatment, and had more metastatic sites in more atypical locations compared to HPV-negative patients, according to research presented today at the 2014 Multidisciplinary Head and […]

Continue reading...

Are combination therapies effective for advanced SCCHN?

Tuesday, March 12, 2013

0 Comments

Source: Author: DrBicuspid Staff In a recent study, researchers from the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center examined whether the addition of multiple drugs to radiation therapy is superior to the current standard of care therapy with one drug and radiation for locally advanced squamous cell carcinoma of the head and neck […]

Continue reading...

Reirradiation for Recurrent Head and Neck Cancer

Wednesday, December 5, 2012

0 Comments

Source: Medscape News Date: November 29, 2012 Abstract Recurrence of head and neck cancer in a previously irradiated volume presents a challenging problem and has poor prognosis. A minority of patients are eligible for the preferred therapy, surgical resection. Systemic therapy is offered to patients with unresectable disease but offers little, if any, chance of […]

Continue reading...

CMC gets $8M to study oral damage from radiation

Friday, September 28, 2012

0 Comments

Source: wcnc.com by Karen Garloch / The Charlotte Observer A research team in the Department of Oral Medicine at Carolinas Medical Center has received an $8 million grant from the National Institutes of Health to study tissue damage in patients who have received high-dose radiation for head and neck cancer. Hospital officials said it is […]

Continue reading...

Oropharyngeal cancer patients with HPV have a more robust response to radiation therapy

Thursday, September 27, 2012

0 Comments

Source: Eurekalert.org (SACRAMENTO, Calif.) — UC Davis cancer researchers have discovered significant differences in radiation-therapy response among patients with oropharyngeal cancer depending on whether they carry the human papillomavirus (HPV), a common sexually transmitted virus. The findings, published online today in The Laryngoscope Journal, could lead to more individualized radiation treatment regimens, which for many […]

Continue reading...

Robots vs. radiation

Friday, July 13, 2012

0 Comments

Source: the-scientist.com Author: Bob Grant Scientists at London, Ontario-based Lawson Health Research Institute have launched the first ever study of the comparative effectiveness of robotic-assisted surgery versus radiation therapy for the treatment of oropharyngeal cancer, or cancer of the back of the throat. Transoral robotic surgery (TORS), a new method for removing tumors from the […]

Continue reading...

Robotic Surgery Is Useful Option for Oral Cancer

Monday, April 30, 2012

0 Comments

Source: Onclive.com Minimally invasive transoral robotic surgery (TORS), used alone or combined with adjuvant therapy, provides good functional and oncologic outcomes in patients with oropharyngeal squamous cell carcinoma (OPSCC), new research suggests. The results were especially impressive in patients with human papillomavirus (HPV) infection, which is currently the most common cause of OPSCC in Europe […]

Continue reading...

Prognostic Significance of HPV Status in Oropharyngeal Cancer

Wednesday, April 18, 2012

0 Comments

OncologySTAT Editorial Team Dr. Maura Gillison is Professor of Medicine, Epidemiology, and Otolaryngology at Ohio State University in Columbus. OncologySTAT: The results of the Radiation Therapy Oncology Group (RTOG) 0129 trial showed that the human papillomavirus (HPV) is an independent prognostic factor in oropharyngeal cancer. Could you tell us about the rationale for this study? […]

Continue reading...

Nobel Laureate Makes Strong Case for Vaccinating Young Males Against HPV to Prevent Cervical Cancer in Females

Tuesday, March 27, 2012

0 Comments

Source: Therapeutics Daily AUSTIN, Texas, March 26, 2012 /PRNewswire-USNewswire/ — Nobel Prize winner Harald zur Hausen called for vaccinating both young males and females for human papilloma virus (HPV) in an achievable quest to eradicate cervical cancer, which is the second leading type of women’s cancer worldwide. Zur Hausen made his remarks at a gathering […]

Continue reading...

Oral Complications After Head/Neck Radiation ‘Underreported’

Monday, March 26, 2012

0 Comments

Source: Elsevier Global Medical News Late oral effects of head and neck cancer therapy are “multiple, underreported, and under-appreciated. “That is the perspective of Joel Epstein, D.M.D., who has worked extensively with head and neck cancer patients experiencing severe dental and other oral problems following radiation therapy. “The acute complications of head and neck cancer therapy […]

Continue reading...